EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]

Jianfeng Huang, Xiaopeng Yuan, Qingfeng Pang, Haowen Zhang, Jiahua Yu, Bo Yang, Leyuan Zhou, Fuzheng Zhang, Fenju Liu

Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-1

DOI: 10.2147/dddt.s614698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Jianfeng Huang und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Huang, J., Yuan, X., Pang, Q., Zhang, H., Yu, J., Yang, B., Zhou, L., Zhang, F., & Liu, F. (2026). Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]. Drug Design, Development and Therapy, Volume 20, 1-1. https://doi.org/10.2147/dddt.s614698

Vancouver

Huang J, Yuan X, Pang Q, Zhang H, Yu J, Yang B, et al. Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]. Drug Design, Development and Therapy. 2026;Volume 20:1-1. doi:10.2147/dddt.s614698

BibTeX
@article{Huang2026,
  author = {Huang, Jianfeng and Yuan, Xiaopeng and Pang, Qingfeng and Zhang, Haowen and Yu, Jiahua and Yang, Bo and Zhou, Leyuan and Zhang, Fuzheng and Liu, Fenju},
  title = {Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction]},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--1},
  doi = {10.2147/dddt.s614698}
}
Kostenlos starten →